The Food and Drug Administration is mandating the labels which will warn about slight increases in the risk of cardiovascular disease, blood clots, and breast cancer. All this comes in response to a study that was halted last summer after some evidence that the risks of long term hormone replacement therapy could outweigh the benefits.
Millions of women use hormone replacement therapy to help control hot flashes and for protection against osteoporosis. Now, along with new warning labels, the FDA is asking doctors to prescribe these drugs at the lowest dose and for the shortest duration for that individual. Experts say treatment duration and dosage decisions must be made on a case by case basis by a woman and her doctor based on the woman's individual risks.